Amber Hill, CEO of Research Grid, on Safely Overcoming Clinical Trial Bottlenecks. Clinical trial teams lose time to patient sourcing, site selection, manual data entry and other tasks. Amber Hill, CEO of Research Grid, discusses how purpose-built AI can safely automate administrative work, improve data quality and help promising treatments reach patients faster.
First seen on govinfosecurity.com
Jump to article: www.govinfosecurity.com/how-purpose-built-ai-speed-up-clinical-trials-a-32312
